Profile | GDS4284 / 1565668_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 59.5538 | 27 |
GSM687648 | Patient 402 control | 91.511 | 34 |
GSM687653 | Patient 403 control | 117.042 | 39 |
GSM687658 | Patient 404 control | 81.1341 | 30 |
GSM687663 | Patient 411 control | 152.128 | 42 |
GSM687668 | Patient 422 control | 97.5398 | 34 |
GSM687673 | Patient 424 control | 88.3053 | 31 |
GSM687678 | Patient 425 control | 64.0183 | 25 |
GSM687683 | Patient 427 control | 76.2424 | 28 |
GSM687688 | Patient 428 control | 87.3071 | 32 |
GSM687695 | Patient 441 control | 20.824 | 5 |
GSM687699 | Patient 443 control | 64.5176 | 24 |
GSM687704 | Patient 444 control | 111.15 | 36 |
GSM687707 | Patient 448 control | 193.207 | 44 |
GSM687712 | Patient 449 control | 20.0195 | 12 |
GSM687719 | Patient 450 control | 127.786 | 35 |
GSM687724 | Patient 451 control | 137.157 | 38 |
GSM687728 | Patient 452 control | 89.9468 | 30 |
GSM687646 | Patient 401 treated 24h | 96.6792 | 34 |
GSM687649 | Patient 402 treated 24h | 43.4596 | 23 |
GSM687665 | Patient 411 treated 24h | 85.8992 | 30 |
GSM687651 | Patient 402 treated 4 weeks | 66.8673 | 26 |
GSM687667 | Patient 411 treated 4 weeks | 26.6862 | 14 |
GSM687670 | Patient 422 treated 24h | 80.8795 | 29 |
GSM687671 | Patient 422 treated 4 weeks | 107.682 | 37 |
GSM687654 | Patient 403 treated 24h | 74.8275 | 31 |
GSM687675 | Patient 424 treated 24h | 80.0016 | 28 |
GSM687685 | Patient 427 treated 24h | 78.8832 | 30 |
GSM687656 | Patient 403 treated 4 weeks | 75.3107 | 32 |
GSM687677 | Patient 424 treated 4 weeks | 68.372 | 28 |
GSM687687 | Patient 427 treated 4 weeks | 44.4003 | 23 |
GSM687692 | Patient 428 treated 4h | 78.6795 | 30 |
GSM687716 | Patient 449 treated 4h | 121.985 | 39 |
GSM687722 | Patient 450 treated 4h | 82.2201 | 28 |
GSM687680 | Patient 425 treated 24h | 133.298 | 40 |
GSM687690 | Patient 428 treated 24h | 96.3393 | 34 |
GSM687700 | Patient 443 treated 24h | 125.882 | 31 |
GSM687705 | Patient 444 treated 24h | 117.937 | 39 |
GSM687714 | Patient 449 treated 24h | 75.0189 | 31 |
GSM687721 | Patient 450 treated 24h | 112.42 | 33 |
GSM687682 | Patient 425 treated 4 weeks | 60.2962 | 26 |
GSM687694 | Patient 428 treated 4 weeks | 51.2417 | 25 |
GSM687702 | Patient 443 treated 4 weeks | 87.7663 | 30 |
GSM687718 | Patient 449 treated 4 weeks | 88.3714 | 31 |
GSM687723 | Patient 450 treated 4 weeks | 81.5359 | 29 |
GSM687661 | Patient 404 treated 4h | 69.6141 | 27 |
GSM687710 | Patient 448 treated 4h | 80.6849 | 30 |
GSM687726 | Patient 451 treated 4h | 135.374 | 37 |
GSM687730 | Patient 452 treated 4h | 302.571 | 42 |
GSM687660 | Patient 404 treated 24h | 156.329 | 38 |
GSM687697 | Patient 441 treated 24h | 173.989 | 39 |
GSM687709 | Patient 448 treated 24h | 89.1395 | 30 |
GSM687725 | Patient 451 treated 24h | 123.183 | 34 |
GSM687729 | Patient 452 treated 24h | 187.693 | 40 |
GSM687727 | Patient 451 treated 4 weeks | 100.526 | 30 |
GSM687731 | Patient 452 treated 4 weeks | 177.558 | 43 |